Status:
COMPLETED
Monitoring Neonatal Resuscitation Trial
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
Leiden University Medical Center
Royal Women's Hospital in Melbourne, Australia
Conditions:
Resuscitation
Neonatal Prematurity
Eligibility:
All Genders
24-28 years
Phase:
NA
Brief Summary
This is a randomized trial to determine if a visible respiratory function monitor (RFM) displaying realtime measurements of delivered inflations improves clinical providers ability to perform positive...
Detailed Description
Recently, it has been demonstrated that the use of a respiratory function monitor (RFM) can guide PPV in the DR.(Wood, Schmolzer) In this study, the New Life Box, (Advanced Life Diagnostics, Weener, G...
Eligibility Criteria
Inclusion
- Gestational age (GA) 24 - 27 6/7 weeks at birth, by best obstetrical
- Receive positive pressure ventilation during delivery room resuscitation
Exclusion
- Known major anomalies including that may affect measured cardiorespiratory parameters: congenital diaphragmatic hernia, trachea-oesophageal fistula, cyanotic heart disease, pulmonary hypoplasia
- RFM not available during resuscitation
Key Trial Info
Start Date :
February 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 20 2021
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT03256578
Start Date
February 20 2017
End Date
September 20 2021
Last Update
November 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104